New Study Explores Nalmefene and Naloxone for Reversal of Respiratory Depression Induced by Fentanyl in a Clinical Opioid Induced Respiratory Depression Model

Findings help build better understanding of the effectiveness of nalmefene in today's opioid overdose environment STAMFORD, Conn. -- Purdue Pharma L.P. ('Purdue') today announced The Journal of Clinical Pharmacologyhas published [...]